New Hope Research Foundation - Crunchbase Company Profile & Funding

Overview

New Hope Research Foundation

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About New Hope Research Foundation

CB Rank

2426369

New Hope Research Foundation focuses on genetic cures for GM2 gangliosidosis and lysosomal storage diseases.

Founded

obfuscation

Private

North Branch, Minnesota, United States

1-10

newhoperesearch.org

Association

Biotechnology

Charity

Non Profit

Key People

Ellen Kraft: Co-Founder
Jack Keimel: President and Co-Founder

Details

Legal Name

New Hope Research Foundation, Inc.

Operating Status

Active

Company Type

Non-profit

Founders

Ellen Kraft, Jack Keimel

About the Company

New Hope Research Foundation is a non-profit organization focused on finding genetic cures for GM2 gangliosidosis and other lysosomal storage diseases. The foundation emphasizes research on gene transfer delivery methods to ensure broad delivery of gene vectors. It aims to provide new hope to families affected by these debilitating conditions

through innovative biotechnological solutions.

Contact Email

contact@newhoperesearch.org

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Gene Therapy

Research and development of gene therapy methods to treat GM2 gangliosidosis and other lysosomal storage diseases, focusing on effective delivery of genetic material to the central nervous system.

Pharmacological Chaperone Therapy

Investigation of small molecule drugs like pyrimethamine to stabilize the hexosaminidase enzyme, increasing its activity in patients with Tay-Sachs disease.